Blackstone

Blackstone, founded in 1985, is a global investment firm headquartered in New York. It manages capital on behalf of pension funds and large institutions across various alternative asset classes, including private equity, real estate, debt, and real assets. The firm also offers fund of funds and multi-manager programs. Blackstone operates globally with offices in key financial hubs and is led by Chairman and CEO Stephen A. Schwarzman, President and COO Jonathan Gray, and Executive Vice Chairman Hamilton E. "Tony" James.

Lionel Assant

Senior Managing Director and Head of European Private Equity

Sachin Bavishi

Senior Managing Director

Greg Blank

Managing Director

Raphael de Botton

Associate

Menes Chee

Senior Managing Director

Brian Dunlap

Managing Director

Nicolas Dupuis

Principal - Blackstone Growth (BXG)

Karl Eber

Managing Director of BX Private Equity Strategies

John Fitzpatrick

Senior Managing Director of PropTech and FinTech BXTI and CTO of Alternative Asset Management Technology

David Foley

Senior Managing Director and CEO of Blackstone Energy Partners

Nicholas Galakatos

Senior Managing Director

Dylan Goldstein

Vice President

Jonathan Gray

President and COO

Wallace Henderson

Senior Managing Director and Infrastructure

Ram Jagannath

Senior Managing Director, Global Head of Healthcare

Hamilton James

Executive Vice Chairman

Laura Johnson

Managing Director

Bilal Khan

Senior Managing Director

Aneek Mamik

Senior Managing Director, New York

Seth Meisel

Senior Managing Director, Private Equity Group

Evan Middleton

Managing Director of Tactical Opportunities Group and Board Member of Sustana Group and Trimark USA

Alan Miyasaki

Senior Managing Director and Head of Asia Acquisitions

William Murphy

Senior Managing Director and CTO

Jonathan Murphy

Managing Director

Paris Panayiotopoulos

Managing Director

Joshua Pang

Analyst

Ramzi Ramsey

Managing Director

Kiran Reddy

Senior Managing Director

Matthew Runkle

Senior Managing Director and Head of Renewables and Midstream, Infrastructure Group

Jim Schaefer

Senior Managing Director

David Schwartz

Senior Managing Director, BX Private Equity Strategies

Mike Shang

Managing Director, Tactical Opportunities Group

Sebastien Sherman

Senior Managing Director and Infrastructure

Mustafa Siddiqui

Head of Energy Private Equity EMEA

Justin Wai

Senior Managing Director

Josh Blaine

Managing Director

Nicholas Kuhar

Senior Managing Director

Brad Colman

Senior Managing Director

Past deals in Pennsylvania

Context Therapeutics

Post in 2024
Context Therapeutics LLC is a clinical-stage biopharmaceutical company based in Philadelphia, Pennsylvania, focused on developing innovative therapies for hormone-responsive cancers. Founded in 2015, the company’s primary aim is to address female hormone-dependent cancers, including breast, ovarian, and endometrial cancer. Context's lead program is Apristor (Onapristone XR), an investigational drug currently in Phase 2 trials for treating progesterone receptor positive metastatic breast and ovarian cancers. The company is also advancing CTX-030916, a potential oral antiprogestin designed for uterine fibroids and endometriosis. Additionally, Context is engaged in a discovery-stage program targeting Sigma1 and has developed CTIM-76, a bispecific antibody aimed at redirecting T-cell-mediated lysis towards malignant cells expressing CLDN6. Through its focused pipeline, Context Therapeutics is committed to creating effective treatments for patients with solid tumors.

AIR Communities

Acquisition in 2024
Apartment Income REIT Corp., also known as AIR Communities, owns and operates apartment communities throughout the United States. AIR Communities manages properties professionally in the majority of major markets, including Boston, Philadelphia, Los Angeles, and Miami.

Harmony Biosciences

Post in 2021
Harmony Biosciences, established in 2017 and based in Plymouth Meeting, Pennsylvania, is a biopharmaceutical company focused on developing and commercializing therapies for patients with rare neurological disorders. Its primary product, WAKIX (pitolisant), is a first-in-class medication designed to increase histamine signaling in the brain, approved for treating cataplexy in adult narcolepsy patients. Harmony Biosciences operates as a subsidiary of Harmony Biosciences Holdings, Inc., which is dedicated to addressing unmet medical needs in this therapeutic area.

Harvest Fund Advisors

Acquisition in 2017
Harvest Fund Advisors, founded in 2005 and based in the suburbs of Philadelphia, specializes in actively managed investment solutions focused on public market energy infrastructure and master limited partnerships (MLPs). The firm primarily serves institutional investors, including real estate investment trusts and business development companies, and manages over $10 billion in assets. Harvest aims to generate strong risk-adjusted returns for its clients by raising capital through separately managed accounts and pooled vehicles that invest in U.S. midstream energy assets, such as pipelines. The company is dedicated to addressing the unique needs of its investors consistently.

Philadelphia Financial Group

Acquisition in 2014
Philadelphia Financial Group is a global specialty insurer and administration company that offers innovative solutions combining insurance and investment management. The firm aims to provide clients worldwide with opportunities to grow their wealth more effectively. It delivers a range of services, including private placement, insurance administration, and investment advisory services, catering to insurance brokers, financial advisors, private banks, law firms, and accounting firms. As an indirect subsidiary of Tiptree Financial, Philadelphia Financial plays a vital role in the broader financial services sector, which encompasses insurance services, specialty finance, asset management, and real estate.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.